PB 80 of 2014
National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2014 (No. 2)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.
Dated          25     September 2014
 
 
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
 
1              Name of Determination
       (1)     This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2014 (No. 2).
       (2)     This Determination may also be cited as PB 80 of 2014.
2              Commencement
                This Determination commences on 1 October 2014.
 
 
3              Amendments to PB 1 of 2010
Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).
 
 
Schedule 1             Amendments
 
[1]      Section 4 Definitions
    omit:
Statins-HP group means the HMG Co-A reductase inhibitor higher potency group.
 
[2]      Schedule 1, Part 2
  omit:
 
1
Candesartan

3
Irbesartan

 
[3]      Omit entry for Schedule 1, Part 7